Overview
Ning Dong is a Hematologist Oncology specialist and a Hematologist in Issaquah, Washington. Dr. Dong is rated as an Experienced provider by MediFind in the treatment of Aleukemic Leukemia Cutis (ALC). Her top areas of expertise are Diffuse Large B-Cell Lymphoma (DLBCL), Non-Hodgkin Lymphoma, B-Cell Lymphoma, Bone Marrow Aspiration, and Lymphadenectomy. Dr. Dong is currently accepting new patients.
Her clinical research consists of co-authoring 19 peer reviewed articles. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- EPO
- PPO
- HMO
- POS
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- OTHER MEDICARE PART D
- EPO
- HMO
- POS
- PPO
- MEDICARE DISCOUNT CARD
- MEDICARE PDP
- OTHER MEDICARE
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
751 Ne Blakely Dr, Suite 1090, Issaquah, WA 98029
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
The Association Of University Physicians
Rachel Salit is a Hematologist Oncology specialist and a Hematologist in Seattle, Washington. Dr. Salit is rated as a Distinguished provider by MediFind in the treatment of Aleukemic Leukemia Cutis (ALC). Her top areas of expertise are Myelofibrosis, Myelodysplastic Syndrome (MDS), Acute Myeloid Leukemia (AML), Graft Versus Host Disease (GvHD), and Bone Marrow Transplant. Dr. Salit is currently accepting new patients.
The Association Of University Physicians
Robert Randolph is a Hematologist Oncology specialist and a Hematologist in Seattle, Washington. Dr. Randolph is rated as a Distinguished provider by MediFind in the treatment of Aleukemic Leukemia Cutis (ALC). His top areas of expertise are Immune Thrombocytopenic Purpura (ITP), Adult Immune Thrombocytopenia, Hemangioma Thrombocytopenia Syndrome, and Pleuropulmonary Blastoma.
Dennis Willerford is an Oncologist and a Hematologist Oncology provider in Poulsbo, Washington. Dr. Willerford is rated as a Distinguished provider by MediFind in the treatment of Aleukemic Leukemia Cutis (ALC). His top areas of expertise are Waldenstrom Macroglobulinemia, Adult Immune Thrombocytopenia, Small Cell Lung Cancer (SCLC), and Lung Adenocarcinoma. Dr. Willerford is currently accepting new patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- B-Cell LymphomaDr. Dong isAdvanced. Learn about B-Cell Lymphoma.
- Bone Marrow AspirationDr. Dong isAdvanced. Learn about Bone Marrow Aspiration.
- Childhood Acute Myeloid Leukemia
- Cutaneous T-Cell Lymphoma (CTCL)
- Diffuse Large B-Cell Lymphoma (DLBCL)
- Drug-Induced ThrombocytopeniaDr. Dong isAdvanced. Learn about Drug-Induced Thrombocytopenia.
- Experienced
- Acute Lymphoblastic Leukemia (ALL)Dr. Dong isExperienced. Learn about Acute Lymphoblastic Leukemia (ALL).
- Acute Myeloblastic Leukemia with Maturation
- Acute Myeloblastic Leukemia without Maturation
- Acute Myeloid Leukemia (AML)Dr. Dong isExperienced. Learn about Acute Myeloid Leukemia (AML).
- Acute Myelomonocytic LeukemiaDr. Dong isExperienced. Learn about Acute Myelomonocytic Leukemia.
- Acute Promyelocytic LeukemiaDr. Dong isExperienced. Learn about Acute Promyelocytic Leukemia.